Survival of advanced lung adenocarcinoma patients and report of the first epidermal growth factor receptor mutations recognized in Colombia

ONCOLGroup study

  • Carlos A. Ortiz Clínica del Country (Bogotá, Colombia)

Metrics

Metrics Loading ...

Author Biography

Carlos A. Ortiz, Clínica del Country (Bogotá, Colombia)
Medicina Interna, Oncología Clínica. Unidad de Oncología, Clínica del Country. Gerente Regional de Investigación en Oncología. Merck Research Laboratories
Published
2019-12-16
How to Cite
Ortiz, C. A. (2019). Survival of advanced lung adenocarcinoma patients and report of the first epidermal growth factor receptor mutations recognized in Colombia: ONCOLGroup study. Acta Medica Colombiana, 34(2), 53-54. Retrieved from https://actamedicacolombiana.com/ojs/index.php/actamed/article/view/1623
Issue
Vol. 34 No. 2 (2009)
Section
Editorial

Acta Medica Colombiana uses the CC-BY 4.0 license. Authors retain all rights over their work.